Pink CEO Reveals Billion Dollar Company Secret w/ Cindy Eckert

Aug 3, 2021

Cindy Eckert, a serial entrepreneur and women’s health advocate, shares her inspiring journey from building a billion-dollar company to advocating for female sexual health. She reveals how she obtained FDA approval for Addyi, the first drug to boost female libido, and her incredible rebound after reacquiring Sprout Pharmaceuticals. With her venture, the PINK CEILING, she champions women in entrepreneurship, emphasizing resilience, purpose, and the importance of open conversations about women's health. Her insights are a must-listen for aspiring entrepreneurs!

Ask episode

AI Snips

Chapters

Transcript

Episode notes

ANECDOTE

Brother's Startup Influence

Cindy Eckert's brother inspired her entrepreneurial journey by joining a startup.
Witnessing his increasing responsibility and equity motivated her to leave the corporate world.

ADVICE

Skin in the Game

Give everyone in your company "skin in the game" through equity or other incentives.
This fosters ownership, accountability, and better decision-making among team members.

ANECDOTE

FDA Rejection and Patient Emails

Cindy Eckert faced FDA rejection for Addyi, the "female Viagra," devastating her team.
She found strength in patient emails, reminding her of the drug's purpose, leading her to fight the FDA.

Get the Snipd Podcast app to discover more snips from this episode

Get the app

IT’S TIME TO “THINK PINK” ON THIS WEEK’S EPISODE!

Cindy Eckert is a DEAR FRIEND, and has become an important ANGEL INVESTOR, SERIAL ENTREPRENEUR, WOMEN’S HEALTH ADVOCATE, AND A VISIONARY HEALTH TECH CEO.

Whether you’re a man or a woman, if you’ve ever had even the faintest glimmer of walking away from your current job and starting your own company, you’re going to absolutely LOVE Cindy Eckert’s story and what you can LEARN from her.

You’re all familiar with what Viagra does for men, but I’ll bet not too many of you know Cindy is the one who got FDA approval for Addyi, the first drug designed to enhance female libido.

After FDA approval, she sold her company, Sprout Pharmaceuticals, to Valeant for a cool $1 BILLION. It wasn’t her first company sale either, having previously sold another start-up for $500 MILLION.

Here's the fascinating part of Cindy’s story.

As part of a lawsuit settlement against Valeant, she reacquired Sprout and the rights to Addyi for next to nothing after Valeant’s stock collapsed by 80% due to insider trading and price manipulation allegations. People like Cindy can’t sit still for very long.

So, she launched a “PINKUBATOR” and a VC/consulting firm called the PINK CEILING as a way of leveling the start-up and entrepreneurial environment for women.

Cindy has a wealth of KNOWLEDGE and EXPERIENCE you're going to want to tap into.

In our ENERGETIC interview, Cindy and I talk quite a bit about the DNA required to be an entrepreneur, how to overcome INEVITABLE SETBACKS, and the MINDSET you need to have in a start-up company,

Most important of all, Cindy stresses that to be successful as an entrepreneur, everyone in your company has to have “SKIN IN THE GAME.”

We also get into the need for establishing the right CORPORATE CULTURE and why treating customers like GOLD is one of the foundational keys to SUCCESS.

If you’re an owner, CEO, or you have management responsibilities where you work, Cindy’s INSIGHTS on finding, hiring, and managing people is something you must hear.

Those of you who are ENTREPRENEURS searching for more CAPITAL for your business need to pay particular attention to what Cindy looks for when she's investing in someone's business.

Cindy may be well known for the PINK outfits she wears every day, but her advice is TRUE BLUE, and you owe it to yourself to hear what she has to say.

Be sure to grab pen and a notepad and take a lot of notes for this one.

👉 SUBSCRIBE TO ED'S YOUTUBE CHANNEL NOW 👈

→ → → CONNECT WITH ED MYLETT ON SOCIAL MEDIA: ← ← ← ▶︎ INSTAGRAM

▶︎ FACEBOOK

▶︎ LINKEDIN

▶︎ TWITTER

▶︎ WEBSITE

Learn more about your ad choices. Visit podcastchoices.com/adchoices